image
BioMarin Pharmaceutical Inc. BMRN
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 63.42
-3.32 %
$ 12.1 B
Market Cap
38.91
P/E
CASH FLOW STATEMENT
159 M OPERATING CASH FLOW
-9.46%
Growth Rates
1Year -9.46%
3Years 23.10%
5Years 51.12%
7Years 15.24%
10Years 16.66%
-111 M INVESTING CASH FLOW
-455.41%
Growth Rates
1Year -455.41%
3Years -27.54%
5Years -7.28%
7Years 18.95%
10Years 9.41%
-18.7 M FINANCING CASH FLOW
-0.41%
Growth Rates
1Year -0.41%
3Years -3.33%
5Years 45.46%
7Years -0.36%
10Years -0.25%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis BioMarin Pharmaceutical Inc.
image
Net Income 168 M
Depreciation & Amortization 104 M
Capital Expenditures -108 M
Stock-Based Compensation 207 M
Change in Working Capital -337 M
Others 3.75 M
Free Cash Flow 51.6 M

Cash Flow

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002 Dec-2001 Dec-2000 Dec-1999 Dec-1998
OPERATING CASH FLOW
Net Income 167.6 141.6 (64.1) 859.1 (23.8) (77.2) (117.0) (630.2) (171.8) (134.0) (176.4) (114.3) (53.8) 205.8 (0.5) 30.8 (15.8) (28.5) (74.3) (187.4) (76.4) (77.4) (57.4) (37.4) (28.1) (12.3)
Depreciation & Amortization 104.4 102.0 108.0 105.2 105.3 95.7 87.9 96.9 47.2 56.7 47.3 45.3 36.1 27.7 21.0 17.6 1.1 12.0 10.1 13.3 9.4 8.5 7.0 7.3 6.6 0.8
Deferred Income Tax (45.0) (52.1) (15.6) (888.9) (82.8) (68.4) 44.5 (228.1) (76.8) (25.5) (9.2) (9.9) 4.4 (230.6) 9.3 3.0 0 0 0 0 0 0 0 0 0 0
Stock Based Compensation 207.1 196.3 197.3 189.7 159.9 148.8 140.3 134.6 111.5 88.2 66.2 47.3 43.9 38.4 36.0 28.3 0 0 0 0 0 0 0 0 0 0
Other Operating Activities 61.6 (115.5) 12.9 44.7 (9.2) (29.3) (70.3) 559.1 (178.1) (28.7) 35.5 16.2 13.3 19.5 2.0 15 K (6.6) (4.0) (6.0) 104.8 (1.6) 17.2 30.1 16.4 7.0 2.6
Change in Working Capital (336.5) (96.4) 66.0 (224.4) (101.1) (49.4) (94.0) (160.3) 46.3 (30.3) (23.1) 33.1 (25.1) (42.1) 19.9 (89.0) (13.2) (29.5) 7.5 4.3 (6.3) (2.0) (2.7) 0.7 1.6 0.8
Cash From Operations 159.3 175.9 304.5 85.4 48.3 20.2 (8.8) (227.8) (221.7) (73.5) (59.6) 17.6 18.8 18.7 87.7 (9.2) (34.5) (50.1) (62.7) (65.1) (74.8) (53.6) (23.1) (12.9) (12.9) (8.1)
INVESTING CASH FLOW
Capital Expenditures (107.6) (131.5) (119.2) (137.5) (163.4) (144.6) (199.2) (148.4) (227.7) (118.8) (65.1) (44.6) (154.2) (49.5) (89.8) (56.4) (22.4) (24.6) (3.0) (24.1) (6.0) (4.9) (17.8) (3.8) (22.9) (6.4)
Other Items (3.6) 111.5 (247.1) 83.9 132.4 409.0 (106.2) (335.7) (951.9) 313.4 (233.7) (151.1) 64.7 (51.9) 10.1 37.3 (128.6) (170.2) 60.6 8.8 (45.0) 75.8 (116.1) 2.2 (45.8) (1.8)
Cash From Investing Activities (111.2) (20.0) (366.3) (53.6) (31.0) 264.4 (305.5) (484.0) (1 179.6) 194.6 (298.8) (195.6) (89.6) (101.3) (79.7) (19.1) (151.0) (194.8) 57.6 (15.3) (51.0) 70.9 (133.9) (1.6) (68.8) (8.2)
FINANCING CASH FLOW
Common Stock Repurchased 0 (54.3) (45.8) (50.0) (42.7) (35.9) (33.5) 0 0 0 (6.4) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Debt Repaid (2.3) (2.6) (3.0) 203.8 (5.1) (375.0) 481.7 0 0 0 713.2 0 (0.9) (0.2) (74.8) 94 K 309.4 163.1 0.2 0.3 118.4 0.2 5.3 0.8 25.6 100 K
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities (85.8) (16.0) 3.0 27.3 (69.6) (13.1) 25.5 14.2 39.7 68.9 33.4 76.8 (3.4) 3.7 11.0 22.9 0 (7.7) 22.1 (30.0) 0.5 1.8 13.2 0 0 100 K
Cash From Financing Activities (18.7) (18.6) 48 K 181.1 (74.7) (388.0) 507.1 727.1 927.9 185.7 746.7 312.3 29.0 3.5 (63.8) 22.8 324.6 295.9 30.1 (27.9) 213.5 3.8 153.0 7.6 95.7 19.7
CHANGE IN CASH
Net Change In Cash 30.6 137.3 (61.9) 211.7 (56.5) (104.0) 189.7 11.3 (478.4) 306.7 388.3 134.3 (41.8) (79.1) (55.7) (5.4) 139.2 51.1 25.0 (108.3) 87.8 21.1 (4.0) (6.9) 14.0 3.4
FREE CASH FLOW
Free Cash Flow 51.6 44.4 185.3 (52.2) (115.1) (124.4) (208.0) (376.2) (449.3) (192.4) (124.8) (27.0) (135.5) (30.7) (2.1) (65.5) (56.9) (74.7) (65.6) (89.2) (80.8) (58.5) (40.9) (16.7) (35.9) (14.5)